ClinicalTrials.Veeva

Menu

Autologous Chondrocyte Transplantation For Articular Cartilage Regeneration

I

Instituto Nacional de Rehabilitacion

Status and phase

Completed
Phase 2
Phase 1

Conditions

Tear; Knee, Cartilage, Articular

Treatments

Device: Arthroscopic matrix encapsulated chondrocyte implantation

Study type

Interventional

Funder types

Other

Identifiers

NCT01503970
017-04-INR

Details and patient eligibility

About

The purpose of this study is to assess safety and efficacy of autologous chondrocyte implantation delivered arthroscopically into chondral lesions of the knee using clinical, biochemical, and MRI outcomes.

Full description

Injuries to the articular cartilage of the knee are common. They produce pain and deteriotation of patients' quality of life. The management of focal chondral lesions continues to be problematic for the treating orthopaedic surgeon. Although many treatment options are currently available, none fulfill the criteria for an ideal repair solution: a hyaline repair tissue that completely fills the defect and integrates well with the surrounding normal cartilage. Autologous chondrocyte implantation is a relatively new cell-based treatment method for full-thickness cartilage injuries that in recent years has increased in popularity, with different studies showing promising results. Typically, this implantation is performed in an open-surgery fashion. In our study the implantation of in-house autologous chondrocyte culture is done arthroscopically, situation that may offer advantages in surgery associated morbidity and patient recovery.

Enrollment

10 patients

Sex

Male

Ages

18 to 50 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients with symptomatic chondral lesions of the knee

Exclusion criteria

  • Inflammatory arthritis
  • Septic arthritis
  • Total meniscectomy
  • Previous microfracture at chondral lesions
  • Paget
  • Ochronosis
  • Acromegalia

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

10 participants in 1 patient group

Chondrocyte implantation
Experimental group
Treatment:
Device: Arthroscopic matrix encapsulated chondrocyte implantation

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems